213 related articles for article (PubMed ID: 21744479)
1. Notch pathway activation induces neuroblastoma tumor cell growth arrest.
Zage PE; Nolo R; Fang W; Stewart J; Garcia-Manero G; Zweidler-McKay PA
Pediatr Blood Cancer; 2012 May; 58(5):682-9. PubMed ID: 21744479
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia.
Kuang SQ; Fang Z; Zweidler-McKay PA; Yang H; Wei Y; Gonzalez-Cervantes EA; Boumber Y; Garcia-Manero G
PLoS One; 2013; 8(4):e61807. PubMed ID: 23637910
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor effects of the Notch pathway in gastrointestinal stromal tumors.
Dumont AG; Yang Y; Reynoso D; Katz D; Trent JC; Hughes DP
Carcinogenesis; 2012 Sep; 33(9):1674-83. PubMed ID: 22764137
[TBL] [Abstract][Full Text] [Related]
4. Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression.
Alaña L; Sesé M; Cánovas V; Punyal Y; Fernández Y; Abasolo I; de Torres I; Ruiz C; Espinosa L; Bigas A; Y Cajal SR; Fernández PL; Serras F; Corominas M; Thomson TM; Paciucci R
Mol Cancer; 2014 Mar; 13():74. PubMed ID: 24684754
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the Notch target gene Hes-1 by TGFalpha induced Ras/MAPK signaling in human neuroblastoma cells.
Stockhausen MT; Sjölund J; Axelson H
Exp Cell Res; 2005 Oct; 310(1):218-28. PubMed ID: 16120441
[TBL] [Abstract][Full Text] [Related]
6. Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer.
Katoh M; Katoh M
Int J Oncol; 2007 Aug; 31(2):461-6. PubMed ID: 17611704
[TBL] [Abstract][Full Text] [Related]
7. The notch 3 intracellular domain represses notch 1-mediated activation through Hairy/Enhancer of split (HES) promoters.
Beatus P; Lundkvist J; Oberg C; Lendahl U
Development; 1999 Sep; 126(17):3925-35. PubMed ID: 10433920
[TBL] [Abstract][Full Text] [Related]
8. RUNX3 directly interacts with intracellular domain of Notch1 and suppresses Notch signaling in hepatocellular carcinoma cells.
Gao J; Chen Y; Wu KC; Liu J; Zhao YQ; Pan YL; Du R; Zheng GR; Xiong YM; Xu HL; Fan DM
Exp Cell Res; 2010 Jan; 316(2):149-57. PubMed ID: 19800882
[TBL] [Abstract][Full Text] [Related]
9. Notch activation inhibits AML growth and survival: a potential therapeutic approach.
Kannan S; Sutphin RM; Hall MG; Golfman LS; Fang W; Nolo RM; Akers LJ; Hammitt RA; McMurray JS; Kornblau SM; Melnick AM; Figueroa ME; Zweidler-McKay PA
J Exp Med; 2013 Feb; 210(2):321-37. PubMed ID: 23359069
[TBL] [Abstract][Full Text] [Related]
10. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
[TBL] [Abstract][Full Text] [Related]
11. Hes1/Hes5 gene inhibits differentiation via down-regulating Hash1 and promotes proliferation in cervical carcinoma cells.
Liu J; Lu WG; Ye F; Cheng XD; Hong D; Hu Y; Chen HZ; Xie X
Int J Gynecol Cancer; 2010 Oct; 20(7):1109-16. PubMed ID: 21495212
[TBL] [Abstract][Full Text] [Related]
12. The Notch signaling cascade in neuroblastoma: role of the basic helix-loop-helix proteins HASH-1 and HES-1.
Axelson H
Cancer Lett; 2004 Feb; 204(2):171-8. PubMed ID: 15013216
[TBL] [Abstract][Full Text] [Related]
13. Repression of chondrogenesis through binding of notch signaling proteins HES-1 and HEY-1 to N-box domains in the COL2A1 enhancer site.
Grogan SP; Olee T; Hiraoka K; Lotz MK
Arthritis Rheum; 2008 Sep; 58(9):2754-63. PubMed ID: 18759300
[TBL] [Abstract][Full Text] [Related]
14. Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling.
Guiu J; Shimizu R; D'Altri T; Fraser ST; Hatakeyama J; Bresnick EH; Kageyama R; Dzierzak E; Yamamoto M; Espinosa L; Bigas A
J Exp Med; 2013 Jan; 210(1):71-84. PubMed ID: 23267012
[TBL] [Abstract][Full Text] [Related]
15. ATF2 maintains a subset of neural progenitors through CBF1/Notch independent Hes-1 expression and synergistically activates the expression of Hes-1 in Notch-dependent neural progenitors.
Sanalkumar R; Indulekha CL; Divya TS; Divya MS; Anto RJ; Vinod B; Vidyanand S; Jagatha B; Venugopal S; James J
J Neurochem; 2010 May; 113(4):807-18. PubMed ID: 20067572
[TBL] [Abstract][Full Text] [Related]
16. HES1 promoter activation dynamics reveal the plasticity, stemness and heterogeneity in neuroblastoma cancer stem cells.
Riya PA; Basu B; Surya S; Parvathy S; Lalitha S; Jyothi NP; Meera V; Jaikumar VS; Sunitha P; Shahina A; Sukumaran R; Nair AS; Dhanesh SB; Jiffy J; Nelson-Sati S; Maliekal TT; Das AV; James J
J Cell Sci; 2022 Nov; 135(22):. PubMed ID: 36321463
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer.
Piazzi G; Fini L; Selgrad M; Garcia M; Daoud Y; Wex T; Malfertheiner P; Gasbarrini A; Romano M; Meyer RL; Genta RM; Fox JG; Boland CR; Bazzoli F; Ricciardiello L
Oncotarget; 2011 Dec; 2(12):1291-301. PubMed ID: 22249198
[TBL] [Abstract][Full Text] [Related]
18. Notch signaling proteins HES-1 and Hey-1 bind to insulin degrading enzyme (IDE) proximal promoter and repress its transcription and activity: implications for cellular Aβ metabolism.
Leal MC; Surace EI; Holgado MP; Ferrari CC; Tarelli R; Pitossi F; Wisniewski T; Castaño EM; Morelli L
Biochim Biophys Acta; 2012 Feb; 1823(2):227-35. PubMed ID: 22036964
[TBL] [Abstract][Full Text] [Related]
19. Exploring the potential relationship between Notch pathway genes expression and their promoter methylation in mice hippocampal neurogenesis.
Zhang Z; Gao F; Kang X; Li J; Zhang L; Dong W; Jin Z; Li F; Gao N; Cai X; Yang S; Zhang J; Ren X; Yang X
Brain Res Bull; 2015 Apr; 113():8-16. PubMed ID: 25701255
[TBL] [Abstract][Full Text] [Related]
20. Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma.
Teider N; Scott DK; Neiss A; Weeraratne SD; Amani VM; Wang Y; Marquez VE; Cho YJ; Pomeroy SL
Neuro Oncol; 2010 Dec; 12(12):1244-56. PubMed ID: 20847082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
